Featured News

FOR IMMEDIATE RELEASE
February 17, 2010

VasSol, Inc. announces Distribution Agreement with Lavi Medical in Israel

VasSol, Inc is pleased to announce an exclusive distribution agreement with Lavi Medical, a leading supplier of advanced medical equipment in Israel, with a specialty in neurosurgical products.

Chicago, Illinois based VasSol, Inc. is the developer of the NOVA (Non-invasive Optimal Vessel Analysis) software for non-invasive volumetric blood flow measurements with magnetic resonance imaging. The test, known as quantitative magnetic resonance angiography (qMRA), combines visual assessment of the blood vessels with a quantitative assessment of blood flow. NOVA is used to diagnose vascular disease and in the treatment planning for stroke and other neurovascular conditions such as arteriovenous malformations and cerebral aneurysms.

NOVA is the first system to use a rotating, 3D model of the vessels to specify exact locations for flow measurement. This enables precise placement of a measurement plane perpendicular to the longitudinal axis of the vessel, a requirement for accurate, reproducible flow measurements. NOVA is currently part of the NIH trial VERiTAS.

VasSol Inc. was founded in 1999 to provide practical solutions for phase-contrast MR flow quantification for daily clinical application. The NOVA technology received FDA 510k clearance in 2001.